Anticoagulation Monitoring Using Activated Clotting Time in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis of Correlation Coefficients
Journal of Cardiothoracic and Vascular Anesthesia · 2024-11 · 38 (11) · 2651-2660
DOI: 10.1053/j.jvca.2024.07.048 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2024-11. Verfasst von Sasa Rajsic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Anticoagulants, Blood Coagulation, Extracorporeal Membrane Oxygenation, Whole Blood Coagulation Time. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to maintain the circuit patency. However, the use of anticoagulation carries a risk of severe hemorrhage, necessitating rigorous monitoring. Activated clotting time (ACT) is a widely used monitoring tool; however, the evidence of its correlation with unfractionated heparin (UFH) infusion dose is limited. Here we aimed to analyze the correlation between ACT and UFH infusion during ECMO. DESIGN: Systematic literature review and meta-analysis of correlation coefficients (Scopus and PubMed, up to July 13, 2024). PROSPERO: CRD42023448888 SETTING: All retrospective and prospective studies PARTICIPANTS: Patients receiving ECMO support INTERVENTION: Anticoagulation monitoring during ECMO support MEASUREMENTS AND MAIN RESULTS: Nineteen studies were included in the analysis, and the meta-analysis encompassed 16 studies. The vast majority of studies (n = 15) found a weak correlation, and no study reported a strong correlation between ACT and UFH infusion dose. The meta-analysis (n = 12,625 samples) identified a weak correlation, with a pooled estimate of correlation coefficients of 0.132 (95% confidence interval 0.03-0.23). The most common adverse events were hemorrhage (pooled incidence, 45%) and thrombosis (30%), and 47% of the patients died during their hospital stay. CONCLUSIONS: Even though ACT is a widely used UFH monitoring tool in ECMO patients, our meta-analysis found a weak correlation between ACT and UFH infusion dose. New trials are needed to investigate the role of emerging tools and to clarify the most appropriate monitoring strategy for patients receiving ECMO support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Austria.
- Department of Anaesthesiology and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Austria. Electronic address: daniel.schwaiger@i-med.ac.at.
- Anesthesia and Intensive Care Department, Pain Therapy Service, Cagliari University, Cagliari, Italy.
- Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Zitieren
APA
Rajsic, S., Schwaiger, D., Schausberger, L., Breitkopf, R., Treml, B., Jadzic, D., Oberleitner, C., & Bukumiric, Z. (2024). Anticoagulation Monitoring Using Activated Clotting Time in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis of Correlation Coefficients. Journal of Cardiothoracic and Vascular Anesthesia, 38(11), 2651-2660. https://doi.org/10.1053/j.jvca.2024.07.048
Vancouver
Rajsic S, Schwaiger D, Schausberger L, Breitkopf R, Treml B, Jadzic D, et al. Anticoagulation Monitoring Using Activated Clotting Time in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis of Correlation Coefficients. Journal of Cardiothoracic and Vascular Anesthesia. 2024;38(11):2651-2660. doi:10.1053/j.jvca.2024.07.048
BibTeX
@article{Rajsic2024,
author = {Rajsic, Sasa and Schwaiger, Daniel and Schausberger, Lukas and Breitkopf, Robert and Treml, Benedikt and Jadzic, Dragana and Oberleitner, Christoph and Bukumiric, Zoran},
title = {Anticoagulation Monitoring Using Activated Clotting Time in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis of Correlation Coefficients},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2024},
volume = {38},
number = {11},
pages = {2651--2660},
doi = {10.1053/j.jvca.2024.07.048}
}
EUVIMED